Latest filing published 03 Aug 2015 for Navidea Biopharmaceuticals, INC., €14k.
Insider track record
No signal scores available.
Closed purchases
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
Brendan A. Ford: trading record in brief
Brendan A. Ford has filed trades across 2 companies (mainly through SEC (Form 4)), most often in Navidea Biopharmaceuticals, Inc. and Cardinal Health Inc. The record holds 35 filings, for trades running from 29 December 2005 to 31 July 2015.
In open-market terms, that means 11 purchases worth €169k on one side and 7 sales worth €545k on the other. The net balance comes to €376k on the selling side. Unlike grants, an open-market purchase is paid for by the insider, at the market price. Outside the open market, there are 15 share grants and 2 option exercises. 2015 to date brings 1 purchase and no sales.
The median purchase comes to €10k.
The record was last updated on 3 August 2015 with a share grant (€14k) in Navidea Biopharmaceuticals, Inc. The last insider purchase was made public on 1 June 2015, 4,179 days ago. Filings reach the SEC (Form 4) feed a median of 3 days after the trade. The legal deadline for a Form 4 is two business days after the transaction. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Brendan A. Ford
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 9,317 shares@ US$1.61Common StockSEC:0001144204-15-045766:0
- 20,000 shares@ US$1.31Common StockSEC:0001144204-15-033347:0
- 22,000 shares0Common StockSEC:0001144204-15-019331:0
- 7,937 shares@ US$1.89Common StockSEC:0001144204-15-006978:0
- 11,446 shares@ US$1.32Common StockSEC:0001144204-14-066983:0
- 10,000 shares@ US$1.03Common StockSEC:0001144204-14-066983:1Canonical exit: 8 Feb 2015 (T+90)
- 20,000 shares0Common StockSEC:0001225208-14-004933:0
- 20,000 shares@ US$1.45Common StockSEC:0001225208-13-023187:0Canonical exit: 6 Feb 2014 (T+90)
- 30,000 shares0Common StockSEC:0001225208-13-007802:0
- 12,250 shares0Common StockSEC:0001225208-13-005553:0
- 17,000 shares0Common StockSEC:0001225208-12-009632:0
- 20,000 shares@ US$2.51Common StockSEC:0001225208-11-020387:0Canonical exit: 17 Nov 2011 (T+90)
- 12,500 shares@ US$1.77Common StockSEC:0001225208-10-024991:0Canonical exit: 13 Feb 2011 (T+90)
- 7,500 shares@ US$1.73Common StockSEC:0001225208-10-024991:1Canonical exit: 13 Feb 2011 (T+90)
- 5,000 shares@ US$1.75Common StockSEC:0001225208-10-024991:2Canonical exit: 13 Feb 2011 (T+90)
- 1,074 shares@ US$68.02Common SharesSEC:0000721371-06-000112:0
- 10,350 shares@ US$27.05Common SharesSEC:0000721371-06-000105:0
- 4,700 shares@ US$67.60Common SharesSEC:0000721371-06-000105:1
- 650 shares@ US$67.62Common SharesSEC:0000721371-06-000105:2
- 2,500 shares@ US$67.55Common SharesSEC:0000721371-06-000105:3
- 200 shares@ US$67.77Common SharesSEC:0000721371-06-000105:4
- 800 shares@ US$67.47Common SharesSEC:0000721371-06-000105:5
- 1,200 shares@ US$67.61Common SharesSEC:0000721371-06-000105:6
- 300 shares@ US$67.62Common SharesSEC:0000721371-06-000105:7
- 6,874 sharesCommon SharesSEC:0000721371-06-000085:0
25 of 29 declarations
